Product labels advise patients to report symptoms that could indicate thyroid tumors, such as neck masses, difficulty swallowing, difficulty breathing, or persistent hoarseness
Its utility as a backbone therapy, with a broad range of risk reduction and treatment benefits may erode the market potential of newer, indication-specific therapies, even in areas where semaglutide is not yet explicitly approved, but initial trial readouts show promising results, e.g
Injections deliver consistent, predictable absorption and typically require once-weekly dosing
Glucagon-like peptide-1 ( GLP-1 ) receptor agonists, such as semaglutide (Wegovy) or tirzepatide (Zepbound), reduce hunger and cravings, making it easier to maintain a calorie deficit during plateaus
It does not have the formal approvals, large safety trials, or standardized manufacturing controls that approved drugs have
This was the first and only FDA-approved option. This was updated to include additional comment from Sprout's CMO